Onyx Pharmaceuticals Announce Third Quarter 2004 Financial Results Webcast and Teleconference

Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a teleconference discussing its third quarter 2004 financial results on Thursday, November 4, 2004, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the third quarter ended September 30, 2004 will be released earlier that day.

Interested parties may access a live webcast of the presentation at:

http://phx.corporate-ir.net/playerlink.zhtml?c=112065&s=wm&e=961508

or by dialing 617-614-4911 and using the passcode 24169366. A replay of the presentation will be available on the Onyx website or by dialing 617-801-6888 and using the passcode 92061130 approximately one hour after the teleconference concludes. The replay will be available through December 4, 2004.

Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at www.onyx-pharm.com.

Back to 2004 Press Releases